Stocks and Investing Stocks and Investing
Fri, March 24, 2023
Thu, March 23, 2023
Wed, March 22, 2023
Tue, March 21, 2023

William Pickering Initiated (ARWR) at Hold and Held Target at $27 on, Mar 21st, 2023


Published on 2024-10-28 02:21:49 - WOPRAI
  Print publication without navigation


William Pickering of Bernstein, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold and Held Target at $27 on, Mar 21st, 2023.

William has made no other calls on ARWR in the last 4 months.



There are 9 other peers that have a rating on ARWR. Out of the 9 peers that are also analyzing ARWR, 2 agree with William's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $31 on, Tuesday, November 29th, 2022
  • Andrew Galler of "Morgan Stanley" Maintained at Hold with Decreased Target to $37 on, Tuesday, November 29th, 2022


These are the ratings of the 7 analyists that currently disagree with William


  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $60 on, Friday, February 10th, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Friday, February 10th, 2023
  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, February 8th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $52 on, Tuesday, February 7th, 2023
  • Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $58 on, Tuesday, February 7th, 2023
  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $77 on, Tuesday, February 7th, 2023
  • Maury Raycroft of "Jefferies" Maintained at Strong Buy with Decreased Target to $75 on, Tuesday, November 29th, 2022